UK approves new genetic test for prostate cancer. The Gen-Probe Progensa urine test, which targets a gene that is overexpressed in prostate cancer, PCA3, will possibly eliminate the need for biopsies to confirm a diagnosis after a PSA test. http://news.bbc.co.uk/2/hi/health/7006107.stm
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.